The Ensign Group, Inc. $ENSG Stock: ProShare Advisors LLC Increases Holdings

ProShare Advisors LLC lifted its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 16.5% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 162,223 shares of the company’s stock after acquiring an additional 23,008 shares during the quarter. ProShare Advisors LLC’s holdings in The Ensign Group were worth $27,902,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. BlackRock Inc. acquired a new position in The Ensign Group during the 2nd quarter worth approximately $937,218,000. Bank of New York Mellon Corp purchased a new stake in shares of The Ensign Group during the second quarter valued at approximately $65,470,000. Paradigm Capital Management Inc. NY purchased a new stake in shares of The Ensign Group during the second quarter valued at approximately $54,742,000. Bank of America Corp DE acquired a new position in shares of The Ensign Group during the second quarter worth $37,509,000. Finally, Wasatch Advisors LP boosted its stake in shares of The Ensign Group by 10.7% in the second quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company’s stock valued at $365,215,000 after purchasing an additional 220,329 shares during the period. Institutional investors and hedge funds own 96.12% of the company’s stock.

The Ensign Group Stock Performance

The Ensign Group stock opened at $181.52 on Monday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.20 and a quick ratio of 1.20. The Ensign Group, Inc. has a 12 month low of $141.58 and a 12 month high of $218.00. The company has a fifty day moving average price of $174.79 and a two-hundred day moving average price of $181.59. The company has a market cap of $10.59 billion, a PE ratio of 27.01, a P/E/G ratio of 1.71 and a beta of 0.66.

The Ensign Group (NASDAQ:ENSG) last issued its earnings results on Tuesday, October 27th. The company reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.97 by $0.06. The Ensign Group had a net margin of 7.03% and a return on equity of 16.79%. The company had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.51 billion. During the same period in the prior year, the company earned $1.64 earnings per share. The firm’s revenue was up 14.5% compared to the same quarter last year. Research analysts expect that The Ensign Group, Inc. will post 7.07 earnings per share for the current year.

The Ensign Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, October 31st. Investors of record on Wednesday, September 30th were paid a dividend of $0.0650 per share. The ex-dividend date was Wednesday, September 30th. This represents a $0.26 annualized dividend and a yield of 0.1%. The Ensign Group’s dividend payout ratio is 3.87%.

Key Stories Impacting The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Earnings beat estimates: Ensign reported third-quarter adjusted earnings of $2.03 per share, exceeding the $1.97 consensus estimate. Revenue increased 14.5% year over year, although it was below analysts’ expectations. The initial earnings reaction included a gap higher in the shares. The Ensign Group Shares Gap Up After Earnings Beat
• Positive Sentiment: Analyst remains constructive: Oppenheimer raised its price target on The Ensign Group from $210 to $215 and maintained an “outperform” rating, implying significant upside from recent trading levels. Oppenheimer analyst rating information
• Neutral Sentiment: Lead-plaintiff deadline: Multiple law firms are soliciting investors who purchased ENSG securities between February 10, 2022, and June 18, 2026, to seek lead-plaintiff status by December 7, 2026. The repeated notices largely restate the same pending litigation rather than announce a new legal development. Ensign securities class action deadline notice
• Negative Sentiment: Litigation overhang: The lawsuits allege Ensign failed to disclose material adverse facts before an approximately 8% stock decline. Continued headlines may increase uncertainty around potential financial, regulatory, and reputational liabilities, helping explain why the stock has decreased despite the earnings beat. Ensign securities-fraud lawsuit announcement

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Oppenheimer increased their target price on The Ensign Group from $210.00 to $215.00 and gave the company an “outperform” rating in a research note on Thursday. Weiss Ratings upgraded shares of The Ensign Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Royal Bank Of Canada restated an “outperform” rating and issued a $228.00 target price on shares of The Ensign Group in a research note on Tuesday, July 28th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a research report on Sunday, October 25th. Finally, Truist Financial set a $210.00 price target on The Ensign Group and gave the stock a “hold” rating in a research note on Thursday. Five investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $218.60.

About The Ensign Group

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.